Knowing that P-gp expression confers resistance to ensartinib, and that one of the most likely explanations for this is the reduced intracellular drug accumulation caused by P-gp-mediated drug efflux [10], we examined the effect of P-gp function on the intracellular accumulation of ensartinib in cancer cells. This evidence concerns the gene PGP and cancer.